Skip to main content
Press release October 29, 2026

Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

Kymera Therapeutics, Inc. (KYMR)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site